Health Bulletin 21/September/2022


Here are the top health reports of the day:

DoP should report to the Department of Health, not the Chemicals and Fertilizers: Parliamentary Body

In order to solve some of the biggest challenges facing medical device manufacturers and to achieve better coordination, the parliamentary committee recently recommended that the central government should bring the Department of Pharmaceuticals (DoP) under the Department of Health and Family Welfare that is currently in place reports to the Ministry of Chemicals and Fertilizers.

The Departmental Parliamentary Committee of the Department of Health and Family Welfare has looked at the issue in detail in its report “Medical Devices: Regulation and Control” and has identified important problem areas and challenges that still need to be solved.

For more details, please refer to the link given below:

DoP should report to Department of Health, not chemicals and fertilizers: Parliamentary body

Only 20 percent of insurance funds under the PMGKP scheme have been paid to family members of doctors who died during COVID-19, RTI reveals

Also Read :  Free youth mental health counseling underutilized in the Yampa Valley

In a shocking revelation, a Right to Information Act (RTI) response from New India Assurance Company Ltd. pointed out that the relatives of doctors who died serving the nation fighting Covid-19 have received only 20% of the total money promised under the Pradhan Mantri Garib Kalyan Package (PMGKP) insurance scheme.

Although the scheme ensured insurance coverage of Rs 50,000 each, the insurance company in its reply to the RTI on September 16 revealed that the total number of beneficiaries under the PMGKP scheme was 1,962 as of August 31 and around Rs 981 crore were paid out were made for this purpose.

For more details, please refer to the link given below:

Only 20 percent of insurance funds under the PMGKP program have been paid to family members of doctors who died during COVID-19, RTI reveals

Relief for MBBS interns in Bihar: Cabinet nods for increasing stipend to Rs 20,000 per month

Also Read :  Selma Blair Shares the Health Reasons She Left DWTS

As a great relief to the MBBS interns in Bihar, the State Cabinet has approved the State Health Ministry’s proposal to increase the stipend from Rs 15,000 per month to Rs 20,000 per month.

This relief isn’t just limited to the medical students, as the cabinet has approved the increase in the amount of internships for the young doctors and staff at the state medical colleges, dental colleges and Ayurvedic colleges as well, HT adds.

For more details, please refer to the link given below:

Relief for MBBS interns in Bihar: Cabinet nods for increasing stipend to Rs 20,000 per month

Study: The risk of bleeding decreases when people stop taking aspirin while taking blood thinners

If you’re already taking a blood thinner, increasing research suggests you may not need to take a second one.

In fact, the risk of bleeding complications decreases significantly when patients taking a commonly prescribed blood thinner stop taking aspirin, according to a Michigan Medicine study.

Also Read :  Europe’s growing mental health care gap – POLITICO

Researchers analyzed over 6,700 patients being treated at anticoagulant clinics across Michigan for venous thromboembolism, or blood clots, and for atrial fibrillation, an irregular heart rhythm that can cause strokes. The patients were treated with the common blood thinner warfarin, but also took aspirin, although they had no history of heart disease.

“We know that aspirin is not a panacea as previously thought and may actually lead to more bleeding events in some of these patients, so we have been working with clinics to reduce the use of aspirin in patients for whom it may be.” not appropriate is necessary,” said Geoffrey Barnes, MD, senior study author and cardiologist at the University of Michigan Health Frankel Cardiovascular Center.

Relation:

Schaefer JK, Errickson J, Gu X, et al. Evaluation of an intervention to reduce aspirin prescription for patients receiving warfarin for anticoagulation. JAMA network open. 2022;5(9):e2231973. doi:10.1001/jamanetworkopen.2022.31973



Source link